CELCCelcuity Inc.
126.85USD-3.91%Mkt Cap: 6.11B USDP/E: Last update: 2026-06-01

Celcuity Inc., a clinical-stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors in the United States. The company's lead drug candidate includes Gedatolis…

Indicators:|

Key Statistics

Company
Market Cap6.11B USD
Enterprise Value6.42B USD
Revenue (TTM)
Gross Profit
Net Income (TTM)-177.04M USD
Revenue/Share
Last Price126.85 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees155
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN
Valuation
P/E (Trailing)
P/E (Forward)179.57
PEG
EV/EBITDA-34.42
EV/Revenue
P/S
P/B120.04
EPS (TTM)-3.90
EPS (Forward)0.74
52W Range
10.5083% of range151.02
52W High151.02 USD
52W Low10.50 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-176.06%
ROA-37.95%
Growth
Revenue Growth
Earnings Growth
Cash Flow & Leverage
Operating CF-153.28M USD
CapEx (TTM)249.00K USD
FCF Margin
FCF Yield-1.82%
Net Debt-63.62M USD
Net Debt/EBITDA0.34
Balance Sheet
Debt/Equity3.20
Current Ratio12.31
Quick Ratio11.65
Book Value/Sh1.107 USD
Cash/Share7.937 USD
Dividends
Fwd Div Rate
Trail. Div Rate0.0000 USD
Div. Yield
5Y Avg Yield
Payout Ratio0.00%
Ex-Div Date
Pay Date
Analyst Consensus
Rating1.2 (Strong Buy)
Target (Mean)169.00 USD
Target Range157.00 USD189.00 USD
# Analysts11
Ownership
Shares Out.48.77M
Float26.81M
Insiders10.01%
Institutions101.30%
Short Interest
Short Ratio8.0d
Short % Float29.45%
Short % Out.19.60%
Shares Short9.56M
Short (prev mo.)8.80M
Technical
SMA 50123.07 (+3.1%)
SMA 20094.14 (+34.7%)
Beta0.09
S&P 52W Chg27.94%
Avg Vol (30d)1.08M
Avg Vol (10d)971.08K
Technical Indicators
RSI (14)51.4
MACD3.0726
MACD Signal3.7716
MACD Hist.-0.6990
BB Upper146.21 USD
BB Middle133.95 USD
BB Lower121.69 USD
BB Width18.31%
ATR (14)8.369 USD
Vol Ratio (20d)0.72x